Last reviewed · How we verify

Nigella Sativa Oil — Competitive Intelligence Brief

Nigella Sativa Oil (Nigella Sativa Oil) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal extract / botanical supplement. Area: Immunology, Inflammation, Metabolic disorders.

marketed Herbal extract / botanical supplement Immunology, Inflammation, Metabolic disorders Small molecule Live · refreshed every 30 min

Target snapshot

Nigella Sativa Oil (Nigella Sativa Oil) — University of Health Sciences Lahore. Nigella sativa oil exerts multi-target anti-inflammatory, antioxidant, and immunomodulatory effects through its active constituent thymoquinone and other phytochemicals.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Nigella Sativa Oil TARGET Nigella Sativa Oil University of Health Sciences Lahore marketed Herbal extract / botanical supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal extract / botanical supplement class)

  1. University of Health Sciences Lahore · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Nigella Sativa Oil — Competitive Intelligence Brief. https://druglandscape.com/ci/nigella-sativa-oil. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: